01 1Sandoz B2B
01 1CEFIXIME
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-11-27
Pay. Date : 2013-09-19
DMF Number : 27527
Submission : 2013-09-27
Status : Active
Type : II
20
Sandoz Gmbh, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is CEFIXIME, with a corresponding US DMF Number 27527.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 27, 2013, and payment made on September 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
